Lucian Dipietro

Person

Cambridge, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted isoindolines as PI3K-alpha inhibitors
- Patent number 12,219,327
- Issue date Feb 4, 2025
- Relay Therapeutics, Inc.
- Lucian V. Dipietro
- H04 - ELECTRIC COMMUNICATION TECHNIQUE
Information Patent Grant
SHP2 phosphatase inhibitors and methods of use thereof
- Patent number 11,629,145
- Issue date Apr 18, 2023
- D. E. Shaw Research, LLC
- Fabrizio Giordanetto
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors
- Patent number 11,591,336
- Issue date Feb 28, 2023
- D. E. Shaw Research, LLC
- Alexander M. Taylor
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of RET
- Patent number 11,279,688
- Issue date Mar 22, 2022
- Blueprint Medicines Corporation
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of the fibroblast growth factor receptor
- Patent number 10,875,837
- Issue date Dec 29, 2020
- Blueprint Medicines Corporation
- Neil Bifulco
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
- Patent number 10,774,070
- Issue date Sep 15, 2020
- Blueprint Medicines Corporation
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of RET
- Patent number 10,584,114
- Issue date Mar 10, 2020
- Blueprint Medicines Corporation
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds useful for treating disorders related to RET
- Patent number 10,227,329
- Issue date Mar 12, 2019
- Blueprint Medicines Corporation
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of the fibroblast growth factor receptor
- Patent number 10,221,154
- Issue date Mar 5, 2019
- Blueprint Medicines Corporation
- Neil Bifulco
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
- Patent number 10,202,365
- Issue date Feb 12, 2019
- Blueprint Medicines Corporation
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds useful for treating disorders related to RET
- Patent number 10,035,789
- Issue date Jul 31, 2018
- Blueprint Medicines Corporation
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of RET
- Patent number 10,030,005
- Issue date Jul 24, 2018
- Blueprint Medicines Corporation
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of the fibroblast growth factor receptor
- Patent number 10,000,490
- Issue date Jun 19, 2018
- Blueprint Medicines Corporation
- Neil Bifulco
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions useful for treating disorders related to kit
- Patent number 9,994,552
- Issue date Jun 12, 2018
- Blueprint Medicines Corporation
- Lucian V. DiPietro
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of the fibroblast growth factor receptor
- Patent number 9,695,165
- Issue date Jul 4, 2017
- Blueprint Medicines Corporation
- Neil Bifulco
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions useful for treating disorders related to kit
- Patent number 9,499,522
- Issue date Nov 22, 2016
- Blueprint Medicines Corporation
- Lucian V. DiPietro
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of the fibroblast growth factor receptor
- Patent number 9,434,700
- Issue date Sep 6, 2016
- Neil Bifulco
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted alkylamine derivatives and methods of use
- Patent number 8,642,624
- Issue date Feb 4, 2014
- Amgen Inc.
- Guoqing Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and methods of use
- Patent number 8,178,557
- Issue date May 15, 2012
- Amgen Inc.
- Michele Potashman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and methods of use
- Patent number 7,531,553
- Issue date May 12, 2009
- Amgen Inc.
- Lucian V. Di Pietro
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted amine derivatives and methods of use
- Patent number 7,514,564
- Issue date Apr 7, 2009
- Amgen Inc.
- Guoqing Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and methods of use
- Patent number 7,435,823
- Issue date Oct 14, 2008
- Amgen Inc.
- Michele Potashman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Kinase inhibitors
- Patent number 7,282,504
- Issue date Oct 16, 2007
- Amgen Inc.
- David M. Armistead
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted amine derivatives and methods of use
- Patent number 7,105,682
- Issue date Sep 12, 2006
- Amgen Inc.
- Guoqing Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted arylamine derivatives and methods of use
- Patent number 7,101,868
- Issue date Sep 5, 2006
- Amgen Inc.
- Daniel Elbaum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted amine derivatives and methods of use
- Patent number 7,102,009
- Issue date Sep 5, 2006
- Amgen Inc.
- Vinod F. Patel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Kinase inhibitors
- Patent number 7,074,789
- Issue date Jul 11, 2006
- Amgen Inc.
- David M. Armistead
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted alkylamine derivatives and methods of use
- Patent number 6,995,162
- Issue date Feb 7, 2006
- Amgen Inc.
- Guoqing Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted alkylamine derivatives and methods of use
- Patent number 6,878,714
- Issue date Apr 12, 2005
- Amgen Inc.
- Benny Askew
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted triazinyl amide derivatives and methods of use
- Patent number 6,864,255
- Issue date Mar 8, 2005
- Amgen Inc.
- Stephanie D. Geuns-Meyer
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20250019380
- Publication date Jan 16, 2025
- Relay Therapeutics, Inc.
- Alessandro BOEZIO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK2 INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20240368122
- Publication date Nov 7, 2024
- Relay Therapeutics, Inc.
- Lucian V. DiPietro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20240287058
- Publication date Aug 29, 2024
- Relay Therapeutics, Inc.
- Alessandro BOEZIO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20230353959
- Publication date Nov 2, 2023
- Relay Therapeutics, Inc.
- Lucian V. DIPIETRO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF RET
- Publication number 20220315560
- Publication date Oct 6, 2022
- BLUEPRINT MEDICINES CORPORATION
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
- Publication number 20210347756
- Publication date Nov 11, 2021
- BLUEPRINT MEDICINES CORPORATION
- Neil Bifulco
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF RET
- Publication number 20200407341
- Publication date Dec 31, 2020
- BLUEPRINT MEDICINES CORPORATION
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLO[3,4-B]PYRAZINE DERIVATIVES AS SHP2 PHOSPHATASE INHIBITORS
- Publication number 20200172546
- Publication date Jun 4, 2020
- Relay Therapeutics, Inc.
- Alexander M. Taylor
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
- Publication number 20200109127
- Publication date Apr 9, 2020
- BLUEPRINT MEDICINES CORPORATION
- Neil Bifulco
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20200062760
- Publication date Feb 27, 2020
- Relay Therapeutics, Inc.
- Fabrizio Giordanetto
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-(PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES AS RET INHIBITORS
- Publication number 20190359591
- Publication date Nov 28, 2019
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF RET
- Publication number 20190185454
- Publication date Jun 20, 2019
- BLUEPRINT MEDICINES CORPORATION
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO RET
- Publication number 20180030032
- Publication date Feb 1, 2018
- Blueprint Medicines Corporation
- Jason D. BRUBAKER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO RET
- Publication number 20180022732
- Publication date Jan 25, 2018
- BLUEPRINT MEDICINES CORPORATION
- JASON D. BRUBAKER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-(PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES AS RET INHIBITORS
- Publication number 20180022731
- Publication date Jan 25, 2018
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
- Publication number 20170253593
- Publication date Sep 7, 2017
- BLUEPRINT MEDICINES CORPORATION
- Neil Bifulco
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
- Publication number 20170174652
- Publication date Jun 22, 2017
- BLUEPRINT MEDICINES CORPORATION
- Neil Bifulco
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF RET
- Publication number 20170121312
- Publication date May 4, 2017
- BLUEPRINT MEDICINES CORPORATION
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT
- Publication number 20170029409
- Publication date Feb 2, 2017
- BLUEPRINT MEDICINES CORPORATION
- Lucian V. DiPietro
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
- Publication number 20150197519
- Publication date Jul 16, 2015
- BLUEPRINT MEDICINES CORPORATION
- Neil Bifulco
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-PIPERIDINYL COMPOUNDS FOR USE AS TANKYRASE INHIBITORS
- Publication number 20150126513
- Publication date May 7, 2015
- Novartis AG
- Christine Hiu-Tung Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
- Publication number 20150119405
- Publication date Apr 30, 2015
- BLUEPRINT MEDICINES CORPORATION
- Neil Bifulco
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT
- Publication number 20140296206
- Publication date Oct 2, 2014
- BLUEPRINT MEDICINES CORPORATION
- Lucian V. DiPietro
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED ALKYLAMINE DERIVATIVES AND METHODS OF USE
- Publication number 20130273004
- Publication date Oct 17, 2013
- Guoqing CHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORGANIC COMPOUNDS
- Publication number 20110092505
- Publication date Apr 21, 2011
- Robin Burgis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds and methods of use
- Publication number 20090176774
- Publication date Jul 9, 2009
- Amgen Inc.
- Michele Potashman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds and methods of use
- Publication number 20070185171
- Publication date Aug 9, 2007
- Julie Germain
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds and methods of use
- Publication number 20060241115
- Publication date Oct 26, 2006
- Michele Potashman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted amine derivatives and methods of use
- Publication number 20060194848
- Publication date Aug 31, 2006
- Amgen Inc.
- Guoqing Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Substituted alkylamine derivatives and methods of use
- Publication number 20060040956
- Publication date Feb 23, 2006
- Guoqing Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Lucian Dipietro

Person

Patents Grantslast 30 patents

Substituted isoindolines as PI3K-alpha inhibitors

SHP2 phosphatase inhibitors and methods of use thereof

Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors

Inhibitors of RET

Inhibitors of the fibroblast growth factor receptor

2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors

Inhibitors of RET

Compounds useful for treating disorders related to RET

Inhibitors of the fibroblast growth factor receptor

2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors

Compounds useful for treating disorders related to RET

Inhibitors of RET

Inhibitors of the fibroblast growth factor receptor

Compositions useful for treating disorders related to kit

Inhibitors of the fibroblast growth factor receptor

Compositions useful for treating disorders related to kit

Inhibitors of the fibroblast growth factor receptor

Substituted alkylamine derivatives and methods of use

Compounds and methods of use

Heterocyclic compounds and methods of use

Substituted amine derivatives and methods of use

Compounds and methods of use

Kinase inhibitors

Substituted amine derivatives and methods of use

Substituted arylamine derivatives and methods of use

Substituted amine derivatives and methods of use

Kinase inhibitors

Substituted alkylamine derivatives and methods of use

Substituted alkylamine derivatives and methods of use

Substituted triazinyl amide derivatives and methods of use

Patents Applicationslast 30 patents

PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF

JAK2 INHIBITORS AND METHODS OF USE THEREOF

PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF

PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF

INHIBITORS OF RET

INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR

INHIBITORS OF RET

PYRAZOLO[3,4-B]PYRAZINE DERIVATIVES AS SHP2 PHOSPHATASE INHIBITORS

INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR

SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF

2-(PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES AS RET INHIBITORS

INHIBITORS OF RET

COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO RET

COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO RET

2-(PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES AS RET INHIBITORS

INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR

INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR

INHIBITORS OF RET

COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT

INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR

4-PIPERIDINYL COMPOUNDS FOR USE AS TANKYRASE INHIBITORS

INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR

COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT

SUBSTITUTED ALKYLAMINE DERIVATIVES AND METHODS OF USE

ORGANIC COMPOUNDS

Compounds and methods of use

Compounds and methods of use

Compounds and methods of use

Substituted amine derivatives and methods of use

Substituted alkylamine derivatives and methods of use